These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24039255)

  • 1. Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease.
    Hunt JM; Bethea B; Liu X; Gandjeva A; Mammen PP; Stacher E; Gandjeva MR; Parish E; Perez M; Smith L; Graham BB; Kuebler WM; Tuder RM
    Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L725-36. PubMed ID: 24039255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical stretching of the pulmonary vein mediates pulmonary hypertension due to left heart disease by regulating SAC/MAPK pathway and the expression of IL-6 and TNF-α.
    Huang W; Liu H; Pan Y; Yang H; Lin J; Zhang H
    J Cardiothorac Surg; 2021 May; 16(1):127. PubMed ID: 33971931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.
    Fayyaz AU; Edwards WD; Maleszewski JJ; Konik EA; DuBrock HM; Borlaug BA; Frantz RP; Jenkins SM; Redfield MM
    Circulation; 2018 Apr; 137(17):1796-1810. PubMed ID: 29246894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.
    Ranchoux B; Nadeau V; Bourgeois A; Provencher S; Tremblay É; Omura J; Coté N; Abu-Alhayja'a R; Dumais V; Nachbar RT; Tastet L; Dahou A; Breuils-Bonnet S; Marette A; Pibarot P; Dupuis J; Paulin R; Boucherat O; Archer SL; Bonnet S; Potus F
    Circ Res; 2019 Aug; 125(4):449-466. PubMed ID: 31154939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent.
    Biasin V; Chwalek K; Wilhelm J; Best J; Marsh LM; Ghanim B; Klepetko W; Fink L; Schermuly RT; Weissmann N; Olschewski A; Kwapiszewska G
    Int J Biochem Cell Biol; 2014 Sep; 54():137-48. PubMed ID: 25016214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathological aspects of pulmonary hypertension].
    Jonigk D; Hoeper MM; Kreipe H; Länger F
    Pathologe; 2012 May; 33(3):183-91. PubMed ID: 22318487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
    Sang P; Kucherenko MM; Yao J; Li Q; Simmons S; Kuebler WM; Knosalla C
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical stretching of pulmonary vein stimulates matrix metalloproteinase-9 and transforming growth factor-β1 through stretch-activated channel/MAPK pathways in pulmonary hypertension due to left heart disease model rats.
    Zhang H; Huang W; Liu H; Zheng Y; Liao L
    PLoS One; 2020; 15(9):e0235824. PubMed ID: 32881898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevant issues in the pathology and pathobiology of pulmonary hypertension.
    Tuder RM; Archer SL; Dorfmüller P; Erzurum SC; Guignabert C; Michelakis E; Rabinovitch M; Schermuly R; Stenmark KR; Morrell NW
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D4-12. PubMed ID: 24355640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension secondary to left-heart failure involves peroxynitrite-induced downregulation of PTEN in the lung.
    Ravi Y; Selvendiran K; Naidu SK; Meduru S; Citro LA; Bognár B; Khan M; Kálai T; Hideg K; Kuppusamy P; Sai-Sudhakar CB
    Hypertension; 2013 Mar; 61(3):593-601. PubMed ID: 23339168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Circulating MicroRNA-206 Level Predicts the Severity of Pulmonary Hypertension in Patients with Left Heart Diseases.
    Jin P; Gu W; Lai Y; Zheng W; Zhou Q; Wu X
    Cell Physiol Biochem; 2017; 41(6):2150-2160. PubMed ID: 28554172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
    Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
    Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term survivors of pediatric heart transplantation: an autopsy study of their pulmonary vascular disease.
    Collins MH; Darragh RK; Caldwell RL; Turrentine MW; Brown JW
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1116-25. PubMed ID: 8719459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.
    Song Y; Coleman L; Shi J; Beppu H; Sato K; Walsh K; Loscalzo J; Zhang YY
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H677-90. PubMed ID: 18552156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of lobar vessels to hypoxic pulmonary hypertension.
    Parks WC; Mecham RP; Crouch EC; Orton EC; Stenmark KR
    Am Rev Respir Dis; 1989 Nov; 140(5):1455-7. PubMed ID: 2817612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of pulmonary hypertension due to left heart disease.
    Liu SF; Yan Y
    Animal Model Exp Med; 2022 Sep; 5(3):197-206. PubMed ID: 35234367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease.
    Wang Q; Guo YZ; Zhang YT; Xue JJ; Chen ZC; Cheng SY; Ou MD; Cheng KL; Zeng WJ
    PLoS One; 2016; 11(7):e0157171. PubMed ID: 27388289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.